Updates in Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-10-07 ms2000000073478817 来自广东省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：cell therapy
经验分享：好的

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-07-12 ms4000000138211847 来自重庆

with editor 2个月了，有他们有没有送外审环节啊？

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-09-14 ms1000000858609486 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：外科
经验分享：很不错

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-08-11 超超不吵吵来自湖南省

偏重的研究方向：炎症性肠病
经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中

27 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-04-12 ms9000001891654753 来自安徽省

请问一下各位大佬，with editor已经半个月了，什么情况？

23 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-07-10 ms5000000761268362 来自甘肃省

各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2023-05-02 左手摸机来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：投稿一个月了还是with editor，打算撤稿了

28 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2021-12-27 小动量

为什么要从MeSH里筛选关键词？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2021-12-27 衣谷

关键词筛选有什么要求？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799838, encodeId=d5fbe99838b8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：普外科;外科肿瘤 经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。 2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept 总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/01/261b7fc046c67ca43d4a17701ea5782e.jpg, createdBy=590374163, createdName=pkuwalker, createdTime=Thu Jun 25 17:55:37 CST 2020, time=2020-06-25, status=1, ipAttribution=)]

2020-06-25 pkuwalker

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：普外科;外科肿瘤
经验分享：这个杂志实际是意大利外科学会的会刊，偏重于普外科。投了一篇仅有3个病例的新技术方面的文章，本来是按照technical note这个栏目准备的（这个栏目有点类似于某些杂志的How I do it，有字数和参考文献字数限制的）。两个审稿人其中有一个建议说应该按照case-series发表，写成包含study design的文章，遂改了格式。审稿人意见都挺友好的。按照审稿意见修改后，字数大幅度增加，也新加了20多篇文献，因审稿人建议语言修改，又找了润色公司润色。很快就接收了。
2020-4-1投稿，4-28修回，6-7投了修改稿，6-24accept
总体还是非常愉快的投稿体验，非常感谢编辑的工作和审稿人的辛苦

122 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务